Clinical Trial Update: Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

View source ↗

Summary

A completed clinical trial update describing a descriptive pharmacoepidemiological study of patients treated with Iressa for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Lung Cancer | Status: COMPLETED